tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

TransMedics price target raised to $130 from $125 at Oppenheimer

Oppenheimer raised the firm’s price target on TransMedics (TMDX) to $130 from $125 and keeps an Outperform rating on the shares following quarterly results. The firm cites a big Q1 beat and raise FY25 guide.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1